Orudis KT

Active Ingredient(s): Ketoprofen
FDA Approved: * October 6, 1995
Pharm Company: * WYETH CONS
Category: Arthritis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Orudis KT Overview

Ketoprofen, (RS)-2-(3-benzoylphenyl)-propionic acid (chemical formula C16H14O3) is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID) with analgesic and antipyretic effects.[1] It acts by inhibiting the body's production of prostaglandin. As of 2015 the cost for a typical month of medication in the United States is 50 to US$100.[2] Contents 1 Medical uses 1.1 Efficacy 2 Interactions 3 Mechanism 4 Available forms 5 Veterinary ...

Read more Orudis KT Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ketoprofen

Recent Orudis KT Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ketoprofen
  • Capsule: 25mg, 50mg, 75mg
  • Capsule, Extended Release: 100mg, 150mg, 200mg
  • Film: 12.5mg
  • Powder: 100%
  • Tablet: 12.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ketoprofen or a similar ingredient: (3 results)

Related Orudis KT Topics:

BAC 2, CYC 2, GAB 6, KTO 10, LID 5
Hi, I just received this cream from my pain management doctor. I have had 2 LS surgeries for severely sequestered discs,... 1 reply
a kt
oval pale yellow with greenish tint and the letters lower case a and the letters in lower case kt...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA